ALA vs DXB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ALA

AROVELLA FPO [ALA]

40LOW

DXB

DIMERIX FPO [DXB]

40LOW

Score Breakdown

ALA DXB
Technical
57
45
Catalyst
50
48
Sentiment
50
50
Fundamental
62
82
Momentum
36
36
Risk Gate
46
50

Key Metrics

ALA Metric DXB
$79.8MMarket Cap$141.1M
950KAvg Volume (20d)3.2M
N/AShort InterestN/A
$0.12552-Week High$0.665
$0.06252-Week Low$0.158
+1.6%Daily Change+2.1%
$0.065Reference Price$0.240
-52.0%ROE-594.5%
-246.9%Profit Margin-219.9%

Active Signals

ALA Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (11 quarters)

DXB Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-04-29
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (15% of range)

Ask Scout AI to compare ALA and DXB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

OPT vs RCE →RAD vs RCE →DXB vs RCE →BOT vs PKY →PKY vs VHL →
ALA Full Analysis → DXB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).